Evidence of oxidative stress in mdx mouse muscle: Studies of the pre- necrotic state

Journal of the Neurological Sciences

Volumn 161, Issue 1, 1998, Pages 77-84

  Disatnik, Marie Helene ^a,b   Dhawan, Jyotsna ^a,b   Yu, Yip ^a,b   Beal, M Flint ^c   Whirl, Michelle M ^a,b   Franco, Alexa A ^a,b   Rando, Thomas A ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Antioxidant enzyme; Free radicals; Mdx mouse; Muscular dystrophy; Oxidative stress

Indexed keywords

ANTIOXIDANT; DYSTROPHIN; FREE RADICAL; MUSCLE ENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRO DERIVATIVE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROCHEMICAL ANALYSIS; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; MUSCLE NECROSIS; MUSCULAR DYSTROPHY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANIMALS; GENE EXPRESSION; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLES; NECROSIS; NITRIC OXIDE; OXIDATIVE STRESS; OXIDOREDUCTASES; REFERENCE VALUES; TYROSINE;

EID: 0032569827     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00258-5     Document Type: Article

References (53)

1. Anderson J.E., Ovalle W.K., Bressler B.H. Electron microscopic and autoradiographic characterization of hindlimb muscle regeneration in the mdx mouse. Anat Rec. 219:1987;243-257.
2. Beal M.F., Matson W.R., Swartz K.J., Gamache P.H., Bird E.D. Kynurenine pathway measurements in Huntington's disease striatum: Evidence for reduced formation of kynurenic acid. J Neurochem. 55:1990;1327-1339.
3. Beckman J.S., Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly. Am J Physiol. 271:1996;C1424-C1437.
4. Beckman J.S., Ye Y.Z., Anderson P.G.et al. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe-Seyler. 375:1994;81-88.
5. Bonilla E., Samitt C.E., Miranda A.F.et al. Duchenne muscular dystrophy: Deficiency of dystrophin at the muscle cell surface. Cell. 54:1998;447-452.
6. Brenman J.E., Chao D.S., Xia H., Aldape K., Bredt D.S. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell. 82:1995;743-752.
7. Brenman J.E., Chao D.S., Gee S.H.et al. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell. 84:1996;757-767.
8. Burr I.M., Asayama K., Fenichel G. Superoxide dismutase, glutathione peroxidase, and catalase in neuromuscular disease. Muscle Nerve. 10:1987;150-154.
9. Chang W.-J., Iannaccone S.T., Lau K.S.et al. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci USA. 93:1996;9142-9147.
10. Chao D.S., Gorospe J.R.M., Brenman J.E.et al. Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J Exp Med. 184:1996;609-618.
11. Crosbie R.H., Straub V., Yun H.-Y.et al. mdx muscle pathology is independent of nNOS perturbation. Hum Mol Genet. 7:1998;823-829.
12. Dangain J., Vrbova G. Muscle development in mdx mutant mice. Muscle Nerve. 7:1984;700-704.
13. Darley-Usmar V., Wiseman H., Halliwell B. Nitric oxide and oxygen radicals: A question of balance. FEBS Lett. 369:1995;131-135.
14. Draper H.H., Hadley M. Malondialdehyde determination as index of lipid peroxidation. Meth Enzymol. 186:1990;421-431.
15. Emery AEH, Duchenne Muscular Dystrophy, New York: Oxford University Press, 1993.
16. Fantini G.A., Yoshioka T. Deferoxamine prevents lipid peroxidation and attenuates reoxygenation injury in postischemic skeletal muscle. Am J Physiol. 264:1993;H1953-H1959.
17. Fenichel G.M., Brooke M.H., Griggs R.C.et al. Clinical investigation in Duchenne muscular dystrophy: Penicillamine and vitamin E. Muscle Nerve. 11:1988;1154-1168.
18. Grinio L.P., Orlov O.N., Prilipko L.L., Kagan V.E. Lipid peroxidation in children with Duchenne's hereditary muscular dystrophy. Bull Exp Biol Med. 98:1984;423-425.
19. Halliwell B, Gutteridge JMC, Free Radicals in Biology and Medicine, 2nd ed., Oxford: Clarendon Press, 1989.
20. Harris E.D. Regulation of antioxidant enzymes. FASEB J. 6:1992;2675-2683.
21. Hauser E., Hoger H., Bittner R., Widhalm K., Herkner K., Lubec G. Oxyradical damage and mitochondrial enzyme activities in the mdx mouse. Neuroped. 26:1995;260-262.
22. Haycock J.W., MacNeil S., Jones P., Harris J.B., Mantle D. Oxidative damage to muscle protein in Duchenne muscular dystrophy. Neuroreport. 8:1996;357-361.
23. Hoffman E.P., Gorospe J.R.M. The animal models of Duchenne muscular dystrophy: Windows on the pathophysiological consequences of dystrophin deficiency. Curr Top Memb. 38:1991;113-154.
24. Hubner C., Lehr H.-A., Bodlaj R.et al. Wheat kernel ingestion protects from progression of muscle weakness in mdx mice, an animal model of Duchenne muscular dystrophy. Ped Res. 40:1996;444-449.
25. Hunter M.I., Mohamed J.B. Plasma antioxidants and lipid peroxidation products in Duchenne muscular dystrophy. Clin Chim Acta. 155:1986;123-131.
26. Imbert N., Vanderbrouck C., Constantin B.et al. Hypoosmotic shocks induce elevation of resting calcium levels in Duchenne muscular dystrophy myotubes contracting in vitro. Neuromusc Disord. 5:1996;351-360.
27. Irintchev A., Wernig A. Muscle damage and repair in voluntarily running mice: Strain and muscle differences. Cell Tissue Res. 249:1987;509-521.
28. Jackson M.J., Jones D.A., Edwards R.H.T. Techniques for studying free radical damage in muscular dystrophy. Med Biol. 62:1984;135-138.
29. Ji L.L., Dillon D., Wu E. Alteration of antioxidant enzymes with aging in rat skeletal muscle and liver. Am J Physiol. 258:1990;R918-R923.
30. Kar N.C., Pearson C.M. Catalase, superoxide dismutase, glutathione peroxidase and thiobarbituric acid-reactive products in normal and dystrophic human muscle. Clin Chem Acta. 94:1979;277-280.
31. Kakulas B.A., Adams R.D. Principles of myopathology as illustrated in the nutritional myopathy of the rottnest quokka (Setonix bracliyurus). Ann NY Acad Sci. 138:1966;90-101.
32. Khurana T.S., Prendergast R.A., Alameddine H.S.et al. Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: Role for calcium homeostasis in extraocular muscle sparing. J Exp Med. 182:1995;467-475.
33. Kristensen S.R. Importance of various types of metabolic inhibition for cell damage caused by direct membrane damage. Mol Cell Biochem. 140:1994;81-84.
34. McArdle A., Edwards R.H.T., Jackson M.J. Time course of changes in plasma membrane permeability in the dystrophin-deficient mdx mouse. Muscle Nerve. 17:1994;1378-1384.
35. McArdle A., Edwards R.H.T., Jackson M.J. How does dystrophin deficiency lead to muscle degeneration? Evidence from the mdx mouse. Neuromusc Disord. 5:1995;445-456.
36. Mechler F., Imre S., Dioszeghy P. Lipid peroxidation and superoxide dismutase activity in muscle and erythrocytes in Duchenne muscular dystrophy. J Neurol Sci. 63:1984;279-283.
37. Mendell J.R., Engel W.K., Derrer E.C. Duchenne muscular dystrophy: Functional ischemia reproduces its characteristic lesions. Science. 172:1971;1143-1145.
38. Menke A., Jockush H. Extent of shock-induced membrane leakage in human and mouse myotubes depends on dystrophin. J Cell Sci. 108:1995;727-733.
39. Murphy M.E., Kehrer J.P. Oxidative stress and muscular dystrophy. Chem-Biol Interact. 69:1989;101-178.
40. Pastoret C., Sebille A. mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci. 129:1995;97-105.
41. Radak Z., Asano K., Inoue M.et al. Superoxide dismutase derivative reduces oxidative damage in skeletal muscle of rats during exhaustive exercise. J Appl Physiol. 79:1995;129-135.
42. Ragusa R.J., Chow C.K., St. Clair D.K., Porter J.D. Extraocular, limb, and diaphragm muscle group-specific antioxidant enzyme activity patterns in control and mdx mice. J Neurol Sci. 139:1996;180-186.
43. Ragusa R.J., Chow C.K., St. Clair D.K., Porter J.D. Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy. Neuromusc Disord. 7:1997;379-386.
44. Rando T.A., Disatnik M.-H., Yu Y., Franco A. Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromusc Disord. 8:1998;14-21.
45. Rando T.A., Crowley R.S., Carlson E., Epstein C.J., Mohapatra P.K. Overexpression of Cu,Zn-superoxide dismutase: A novel cause of murine muscular dystrophy. Ann Neurol. 44:1998;381-386.
46. Roelofs R.I., de Arango G.S., Law P.K., Kinsman D., Buchanan D.C., Park J.H. Treatment of Duchenne's muscular dystrophy with penicillamine. Arch Neurol. 36:1979;266-268.
47. Stern L.Z., Ringel S.P., Ziter F.A.et al. Drug trial of superoxide dismutase in Duchenne's muscular dystrophy. Arch Neurol. 39:1982;342-346.
48. Straub V., Rafael J.A., Chamberlain J.S., Campbell K.P. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol. 139:1997;375-385.
49. Tanabe Y., Esaki K., Nomura T. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol. 69:1986;91-95.
50. Vihko V., Rantamaki J., Salminen A. Exhaustive physical exercise and acid hydrolase activity in mouse skeletal muscle. Histochem. 57:1978;237-249.
51. Wehling M., Stull J.T., McCabe T.J., Tidball J.G. Sparing of mdx extraocular muscles from dystrophic pathology is not attributable to normalized concentration or distribution of neuronal nitric oxide synthase. Neuromusc Disord. 8:1998;22-29.
52. Wink D.A., Hanbauer I., Krishna M.C., DeGraff W., Gamson J., Mitchell J.B. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci USA. 90:1993;9813-9817.
53. Wink D.A., Cook J.A., Pacelli R., Liebman J., Krishna M.C., Mitchell J.B. Nitric oxide (NO) protects against cellular damage by reactive oxygen species. Toxicol Lett. 82 83:1995;221-226.